UNH Coverage for Tandem Diabetes Care (TNDM) Pump a 'Clear Positive' - Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $15.68 -1.01%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 62
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 62
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien reiterated an Overweight rating and $90.00 price target on Tandem Diabetes Care (NASDAQ: TNDM), noting that UNH will formally cover the company's pump.
The analyst said this is a "clear positive for the name."
For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.
Shares of Tandem Diabetes Care closed at $87.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Tandem Diabetes Care (TNDM) at Equalweight
- Jefferies Starts Vicore Pharma Holding (VICO:SS) at Buy
- UBS Downgrades Pearson PLC (PSON:LN) (PSO) to Neutral
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
